Hikma and Amarin's generic drug case heads to Supreme Court arguments

Credit: Viktoria Nikolova for Endpoints News April 28, 2026 01:14 PM EDTUpdated 02:33 PM PharmaLaw The Supreme Court will de­ter­mine how a fish oil pill shakes up the gener­ics mar­ket Nicole DeFeudis Senior Reporter When the Supreme Court hears ar­gu­ments this week over a pre­scrip­tion-strength pill de­rived from fish oil, the en­tire gener­ic drug in­dus­try will be watch­ing. The … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER